SCHEMBL6071885

SCHEMBL6071885

O=C(O)c1nnn(Cc2cc(C(F)(F)F)cc(C(F)(F)F)c2)c1O

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.45
GAA P10253 1/20 0.45
HPGD P15428 2/20 0.43
AKR1C3 P42330 2/20 0.41
AKR1C2 P52895 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.40
USP2 O75604 5/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2C19 P33261 1/20 0.40
PTGES O14684 1/20 0.39
TP53 P04637 1/20 0.39
POLB P06746 1/20 0.38
CYP3A4 P08684 3/20 0.38
TSHR P16473 2/20 0.38
HIF1A Q16665 1/20 0.38
MAPT P10636 1/20 0.38
CYP2D6 P10635 4/20 0.38
PTGER4 P35408 1/20 0.37
RORC P51449 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4637929 0.85 HPGD (0.45) ALDH1A1GAAHPGDAKR1C3AKR1C2
SCHEMBL5797576 0.85 HPGD (0.62) ALDH1A1GAAHPGDSMN1; SMN2CYP1A2
SCHEMBL4639498 0.85 ALDH1A1 (0.44) ALDH1A1GAAHPGDAKR1C3SMN1; SMN2
SCHEMBL4637791 0.82 CYP19A1 (0.47) ALDH1A1AKR1C3SMN1; SMN2TP53TSHR
SCHEMBL5797506 0.82 AKR1C3 (0.45) ALDH1A1GAAHPGDAKR1C3AKR1C2
SCHEMBL5797474 0.82 ALDH1A1 (0.42) ALDH1A1GAAHPGDAKR1C3SMN1; SMN2
SCHEMBL4638473 0.81 ALDH1A1 (0.65) ALDH1A1GAAHPGDAKR1C3AKR1C2
SCHEMBL5796504 0.81 ALDH1A1 (0.44) ALDH1A1GAAHPGDAKR1C3AKR1C2
SCHEMBL5797687 0.80 CASP1 (0.43) ALDH1A1GAAHPGDSMN1; SMN2USP2
SCHEMBL4637749 0.79 ALDH1A1 (0.53) ALDH1A1GAAHPGDSMN1; SMN2USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060160794-A1 Tachykinin receptor antagonists ELI LILLY AND COMPANY 2006-07-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060160794-A1 Tachykinin receptor antagonists TACR1, TACR2, PROKR1 ALDH1A1 1815/4885GAA 1942/4885HPGD 1291/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.